The Limited Usefulness of Routine Creatine Kinase Testing in Psychiatric Patients
Author Information
Author(s): Scott Fraser, Matt Butler, Jonathan P. Rogers
Primary Institution: South London and Maudsley NHS Foundation Trust
Hypothesis
Routine testing of creatine kinase (CK) on admission to psychiatric inpatient units may have limited clinical utility.
Conclusion
Routine screening for creatine kinase in psychiatric inpatients does not effectively identify neuroleptic malignant syndrome and has minimal impact on clinical management.
Supporting Evidence
- Only 14 patients received a new diagnosis after abnormal CK results, indicating low diagnostic yield.
- No cases of neuroleptic malignant syndrome were identified in the study.
- Routine CK testing had minimal impact on clinical management, with most changes being minor adjustments.
Takeaway
Doctors checked a blood test called creatine kinase for many patients in a mental hospital, but it didn't help them find serious problems or change how they treated the patients.
Methodology
A descriptive retrospective cohort study was conducted using an electronic case register to analyze psychiatric inpatient admissions over four years.
Potential Biases
Potential bias due to reliance on electronic records and the possibility of unrecorded interventions.
Limitations
The study relied on the accuracy of clinical records and was limited to one mental health trust, which may affect generalizability.
Participant Demographics
{"age":{"mean":40.7,"standard_deviation":15.7},"sex_distribution":{"male":49.4,"female":50.6}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website